FDA issued a Warning Letter to OriGen Biomedical, Inc. on 12/20/2018 as a result of this inspection.
483 OriGen Biomedical Jul 2018
483 OriGen Biomedical Jul 2018Iris Macinnes FDA$119.00 - Available Now
FDA investigators audited the OriGen Biomedical - Austin, TX, United States facility and issued inspectional observations (via FDA 483) on 05 Jul 2018.
Add To Cart
- Category: Medical Devices & Rad Health
- Inspection end: 05 Jul 2018
- Location: Austin, United States
- FEI: 1000160256